Empirical Validation & Intellectual Property

Clinical Evidence & Patents

The inventions of Dr. Muhammed Aslam Nasir are among the most rigorously investigated supraglottic technologies in medical history, validated by multi-center trials in JAMA, endorsed by European & American resuscitation councils, and protected across multinational patent registries.

JAMA AIRWAYS-2 TrialDAS Guidelines Algorithm10+ Global Patents
Clinical Research and Medical Device Trial Data
Peer-Reviewed Evidence BaseOver 200+ publications across anaesthesia journals
DIFFICULT AIRWAY SOCIETYMACEWEN MEDAL • 2016DR. MUHAMMED ASLAM NASIR
Official DAS UK Macewen Medal (Conferred 2016)
Highest Distinction in Global Airway Management

The Macewen Medal

Named in honor of Sir William Macewen (1848–1924), the Scottish surgeon who performed the world’s first recorded tracheal intubation for anaesthesia in 1878, the Macewen Medal is awarded by the Difficult Airway Society (DAS, UK) to individuals who have made extraordinary, lasting contributions to airway clinical practice.

Citation for Dr. Muhammed Aslam Nasir (2016)

"Conferred for pioneering the non-inflatable supraglottic seal concept and inventing the i-gel®, transforming routine clinical anaesthesia and emergency resuscitation protocols across hospitals and paramedical services worldwide."

Awarding BodyDifficult Airway Society (UK)
Clinical Impact100+ Countries Adopted
TECHNICAL SPECIFICATION & IP BLUEPRINT

Dr. Muhammed Aslam Nasir Patent Architecture

The foundational engineering disclosures protecting the non-inflatable anatomical perilaryngeal airway seal.

PORTFOLIO: 10+ GLOBAL PATENTS
FIG. 3A • LONGITUDINAL SECTIONAL VIEWPATENT NO: US 7,464,710 B2DR. M. A. NASIR
15.0 mm OD14 (Gastric Lumen)22 (SEBS Gel Seal)18 (Epiglottic Rest)ASSIGNEE: TALRIA LIMITED DMCCINVENTOR: DR. M. A. NASIRSTATUS: GRANTED & VALID
Primary Patent Registration

Nasir Laryngeal Airway (NLA / i-gel®)

US Patent:US 7,464,710 B2
European Patent:EP 1,450,893 B1
WIPO International:WO 2004/004815 A1
Veterinary Extension:US 8,820,326 B2 (v-gel)
Anatomically pre-formed non-inflatable cuff mirroring perilaryngeal cartilage.
Integral gastric channel running alongside ventilation lumen with esophageal outlet.
Integrated bite block protecting internal airway and fiberscope conduits.
Peer-Reviewed Literature

Landmark Clinical Trials & Guidelines

Over 200+ independent studies validate the safety, seal pressure, and rapid insertion of Dr. Nasir’s airway architectures.

Human Medicine (i-gel)JAMA (Journal of the American Medical Association) • 2018
JAMA. 2018;320(8):779-791. doi:10.1001/jama.2018.11597

Effect of a Strategy of a Supraglottic Airway Device vs Tracheal Intubation During Out-of-Hospital Cardiac Arrest (AIRWAYS-2 Trial)

Authors: Benger JR, Kirby K, Black S, et al.

A landmark multicenter cluster-randomized clinical trial involving 9,296 adult patients with non-traumatic out-of-hospital cardiac arrest attended by 1,523 paramedics from four ambulance services in England.

Key Clinical Finding: Demonstrated high initial airway placement success rates for i-gel® (87.4% on first attempt), confirming its reliability as a frontline resuscitation airway in emergency medical systems.
Resuscitation & GuidelinesBritish Journal of Anaesthesia • 2015
Br J Anaesth. 2015;115(6):827-848

Difficult Airway Society 2015 Guidelines for Management of Unanticipated Difficult Intubation in Adults

Authors: Frerk C, Mitchell VS, McNarry AF, et al.

The definitive guidelines for unanticipated difficult intubation in general anaesthesia. Specifies 2nd generation supraglottic airway devices with gastric channels as Plan B rescue devices.

Key Clinical Finding: Recommends second-generation supraglottic airways such as i-gel® for rescue oxygenation due to superior seal pressures and esophageal vent protection against aspiration.
Human Medicine (i-gel)Resuscitation • 2008
Resuscitation. 2008;79(3):472-477

Size 4 i-gel Airway Insertion During Chest Compressions in a Manikin Simulation

Authors: Gatward JJ, Thomas MJ, Nolan JP, Cook TM.

Investigated the feasibility and speed of inserting an i-gel airway during continuous uninterrupted external cardiac compressions.

Key Clinical Finding: 100% of insertions succeeded without interrupting CPR chest compressions, with median insertion times under 8 seconds.
Veterinary Medicine (v-gel)Veterinary Anaesthesia and Analgesia • 2013
Vet Anaesth Analg. 2013;40(6):578-585

Evaluation of a New Supraglottic Airway Device in Anaesthetised Feline Patients

Authors: Crotaz I, et al.

Prospective veterinary clinical trial assessing ease of placement, seal quality, and safety of the feline v-gel® supraglottic device compared to traditional cuffed endotracheal tubes.

Key Clinical Finding: v-gel® provided immediate, non-traumatic airway placement, stable capnography waveforms, zero tracheal wall damage, and significantly reduced postoperative cough.
Veterinary Medicine (v-gel)Journal of Exotic Pet Medicine • 2016
J Exot Pet Med. 2016;25(2):120-128

Clinical Safety and Hemodynamic Stability of v-gel in Pet Rabbits Undergoing Routine Surgery

Authors: Prasse L, Selleri P, et al.

Assessed the veterinary challenge of rabbit airway management, where traditional blind endotracheal intubation results in severe glottic edema and mortality rates of over 1.3%.

Key Clinical Finding: Achieved a 98% first-pass placement rate in rabbits without trauma, ensuring patent airway and eliminating post-anaesthetic laryngitis.
Veterinary Medicine (v-gel)Frontiers in Veterinary Science • 2020
Front Vet Sci. 2020;7:582231

Evaluation of the v-gel Advanced Supraglottic Airway Device in Cats Undergoing Controlled Positive-Pressure Ventilation

Authors: Barletta M, Kleine SA, et al.

Multi-parameter evaluation of the next-generation v-gel® advanced device under controlled mechanical ventilation and capnographic monitoring.

Key Clinical Finding: Confirmed robust seal pressures reaching 18 to 22 cmH2O, maintaining optimal ventilation without leakage of volatile anaesthetic gas into the surgical suite.
Intellectual Property Protection

Global Patent Portfolio

TALRIA LIMITED DMCC holds and manages foundational patents covering non-inflatable anatomical airway geometry, dual-lumen suction systems, and species-matched veterinary seals.

US 7,412,977 B2Granted & Globally Enforced
United States Patent and Trademark Office (USPTO)

Laryngeal Airway Device

Pioneering patent covering an anatomical airway device comprising a flexible non-inflatable cuff configured to closely match the contours of the perilaryngeal tissues and epiglottic valleculae, avoiding mucosal ischemia.

Inventor: Dr. Muhammed Aslam Nasir
Assignee: Talria Limited / Talria Limited DMCC
US 8,020,558 B2Granted & Licensed
United States Patent and Trademark Office (USPTO)

Airway Device with Integrated Gastric Channel and Bite Block

Covers second-generation airway device innovations featuring an integral dorsal esophageal conduit enabling gastric aspiration and venting, integrated with buccal stabilization structures.

Inventor: Dr. Muhammed Aslam Nasir
Assignee: Talria Limited / Talria Limited DMCC
EP 1644067 B1Granted across 28 European member states
European Patent Office (EPO)

Nasir Laryngeal Airway Device and Supraglottic Sealing Mechanism

European foundational patent covering the geometry and thermoplastic elastomeric properties providing physiological seal pressures without cuff pressure monitoring.

Inventor: Dr. Muhammed Aslam Nasir
Assignee: Talria Limited DMCC
US 9,662,467 B2Granted
United States Patent and Trademark Office (USPTO)

Species-Specific Veterinary Supraglottic Airway Device

Protects anatomical 3D pharyngolaryngeal bowl configurations specific to feline, lagomorph, and canine airway structures, preventing tracheal ring injury.

Inventor: Dr. Muhammed Aslam Nasir
Assignee: Talria Limited / Docsinnovent Ltd
WO 2021/181112 A1International Publication
World Intellectual Property Organization (WIPO / PCT)

Advanced Anatomical Airway with Dual-Lumen Telemetric Monitoring

Next-generation supraglottic device incorporating sensor conduits, integrated capnography sample ports, and reinforced epiglottic barrier structures.

Inventor: Dr. Muhammed Aslam Nasir, Talha Nasir
Assignee: Talria Limited DMCC

Intellectual Property & Licensing Inquiries

For technology transfer agreements, patent licensing, or regional manufacturing rights, please contact our legal and business development team.

Contact Licensing →